Literatur
-
1
Myerburg R J, Kessler K M, Castellanos A.
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
Ann Intern Med.
1993;
119
1187-1197
-
2
Tan H L, Hofman N, van Langen I M, van der Wal A C, Wilde A M.
Sudden unexplained death: Heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.
Circulation.
2005;
112
207-213
-
3
Splawski I, Shen J, Timothy K W, Lehmann M H, Priori S, Robinson J L. et al .
Spectrum of mutations in long QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
Circulation.
2000;
102
1178-1185
-
4
Moss A J, Zareba W, Benhorin J, Locati E H, Hall W J, Robinson J L. et al .
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.
Circulation.
1995;
92
2929-2934
-
5
Jervell A, Lange-Nielsen F.
Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death.
Am Heart J.
1957;
54
59-68
-
6
Moss A J, Schwartz P J, Crampton R S, Tzivoni D, Locati E H, MacCluer J. et al .
The long QT syndrome. Prospective longitudinal study of 328 families.
Circulation.
1991;
84
1136-1144
-
7
Romano C.
Congenital Cardiac Arrhythmia.
Lancet.
1965;
17
658-659
-
8
Priori S G, Schwartz P J, Napolitano C, Bloise R, Ronchetti E, Grillo M. et al .
Risk stratification in the long-QT syndrome.
N Engl J Med.
2003;
348
1866-1874
-
9
Schwartz P J, Priori S G, Spazzolini C, Moss A J, Vincent G M, Napolitano C. et al .
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
Circulation.
2001;
103
89-95
-
10
Zareba W, Moss A J, Daubert J P, Hall W J, Robinson J L, Andrews M.
Implantable cardioverter defibrillator in high-risk long QT syndrome patients.
J Cardiovasc Electrophysiol.
2003;
14
337-341
-
11
Priori S G, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P. et al .
Task Force on sudden cardiac death of the European Society of Cardiology.
Eur Heart J.
2001;
22
1374-1450
-
12
Gussak I, Brugada P, Brugada J, Wright R S, Kopecky S L, Chaitman B R, Bjerregaard P.
Idiopathic short QT interval: a new clinical syndrome?.
Cardiology.
2000;
94
99-102
-
13
Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richiardi E, Borggrefe M.
Short QT Syndrome: a familial cause of sudden death.
Circulation.
2003;
108
965-970
-
14
Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M. et al .
Sudden death associated with short-QT syndrome linked to mutations in HERG.
Circulation.
2004;
109
30-35
-
15
Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro J, Dumaine R. et al .
Further insights into the effect of quinidine in Short QT Syndrome caused by a mutation in HERG.
J Cardiovasc Electrophysiol.
2005;
16
54-58
-
16
Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calo L. et al .
Short QT syndrome: pharmacological treatment.
J Am Coll Cardiol.
2004;
43
1494-1499
-
17
Priori S G, Pandit S V, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A. et al .
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
Circ Res.
2005;
96
800-807
-
18
Bellocq C, van Ginneken A C, Bezzina C R, Alders M, Escande D, Mannens M M, Baro I, Wilde A A.
Mutation in the KCNQ1 gene leading to the short QT-interval syndrome.
Circulation.
2004;
109
2394-2397
-
19
Rautaharju P M, Zhou S H, Wong S, Calhoun H P, Berenson G S, Prineas R, Davignon A.
Sex differences in the evolution of the electrocardiographic QT interval with age.
Can J Cardiol.
1992;
8
690-695
-
20
Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U, Borggrefe M.
Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
J Cardiovasc Electrophysiol.
2003;
14
1273-1277
-
21
Brugada P, Brugada J.
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
J Am Coll Cardiol.
1992;
20
1391-1396
-
22
Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J.
Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.
J Cardiovasc Electrophysiol.
2003;
14
455-457
-
23
Priori S G, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U. et al .
Natural history of Brugada syndrome: insights for risk stratification and management.
Circulation.
2002;
105
1342-1347
-
24
Yan G X, Antzelevitch C.
Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
Circulation.
1999;
100
1660-1666
-
25
Matsuo K, Akahoshi M, Nakashima E, Suyama A, Seto S, Hayano M, Yano K.
The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades.
J Am Coll Cardiol.
2001;
38
765-770
-
26
Furuhashi M, Uno K, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T. et al .
Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population.
Heart.
2001;
86
161-166
-
27
Hermida J S, Lemoine J L, Aoun F B, Jarry G, Rey J L, Quiret J C.
Prevalence of the brugada syndrome in an apparently healthy population.
Am J Cardiol.
2000;
86
91-94
-
28
Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D. et al .
Brugada Syndrome: Report of the Second Consensus Conference.
Circulation.
2005;
111
659-670
-
29
Brugada J, Brugada R, Brugada P.
Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.
Circulation.
1998;
97
457-460
-
30
Eckardt L, Kirchhof P, Schulze-Bahr E, Rolf S, Ribbing M, Loh P. et al .
Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats.
Eur Heart J.
2002;
23
1394-1401
-
31
Chen Q, Kirsch G E, Zhang D, Brugada R, Brugada J, Brugada P. et al .
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.
Nature.
1998;
392
293-296
-
32
Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W.
Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.
Hum Mutat.
2003;
21
651-652
-
33
Brugada R, Brugada J, Antzelevitch C, Kirsch G E, Potenza D, Towbin J A, Brugada P.
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.
Circulation.
2000;
101
510-515
-
34
Rolf S, Bruns H J, Wichter T, Kirchhof P, Ribbing M, Wasmer K. et al .
The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol.
Eur Heart J.
2003;
24
1104-1112
-
35
Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P.
Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.
Circulation.
2002;
105
73-78
-
36
Brugada J, Brugada R, Brugada P.
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
Circulation.
2003;
108
3092-3096
-
37
Brugada P, Geelen P, Brugada R, Mont L, Brugada J.
Prognostic value of electrophysiologic investigations in Brugada syndrome.
J Cardiovasc Electrophysiol.
2001;
12
1004-1007
-
38
Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas G, Spehl S. et al .
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
Heart Rhythm.
2005;
2
254-260
-
39
Eckardt L, Probst V, Smits J, Schulze-Bahr E, Wolpert C, Schimpf R. et al .
Long-term prognosis of individuals with right precordial ST-elevation - Brugada Syndrome.
Circulation.
2005;
111
257-263
-
40
Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc D D, Coumel P.
Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients.
Circulation.
1995;
91
1512-1519
-
41
Nam G B, Burashnikov A, Antzelevitch C.
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
Circulation.
2005;
111
2727-2733
-
42
Francis J, Sankar V, Krishnan V, Prior S.
Catecholaminergic polymorphic ventricular tachycardia.
Heart Rhythm.
2005;
2
550-554
-
43
Swan H, Laitinen P, Kontula K, Toivonen L.
Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
J Cardiovasc Electrophysiol.
2005;
16
162-166
Priv.-Doz. Dr. med. Christian Wolpert
I. Medizinische Klinik
Universitätsklinikum Mannheim · Theodor-Kutzer-Ufer 1 - 3 · 68167 Mannheim
Email: christian.wolpert@med.ma.uni-heidelberg.de
